Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,220.40
(
1.74%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
96.69
(
1.76%
)
Bitcoin
78,847.21
(
3.30%
)
News Focus
News Focus
Post# of 257437
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

EyeGuy

Send PM Follow Ignore
Followers 0
Posts 40
Boards Moderated 0
Alias Born 03/07/2006

EyeGuy

Re: DewDiligence post# 50387

Tuesday, 07/31/2007 11:32:15 AM

Tuesday, July 31, 2007 11:32:15 AM

Post# of 257437
RE: Targegen Ph2

Anyone know where this trial is taking place? Almost impossible to ethically conduct this kind of study in many countries given success of Lucentis/Avastin.

<TargeGen, Inc. today announced that the Company has initiated a multi-center Phase II clinical trial of topically applied TG100801 in patients with age-related macular degeneration (AMD). >
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today